Author Correction: Efficient C•G-to-G•C base editors developed using CRISPRi screens, target-library analysis, and machine learning

Luke W Koblan^#^{1

2

3}, Mandana Arbab^#^{1

2

3}, Max W Shen^#^{1

2

3

4}, Jeffrey A Hussmann^{5

6

7

8

9}, Andrew V Anzalone^{1

2

3}, Jordan L Doman^{1

2

3}, Gregory A Newby^{1

2

3}, Dian Yang^{5

7

8

9}, Beverly Mok^{1

2

3}, Joseph M Replogle^{5

7

10

11

8

9}, Albert Xu^{5

6

10

12}, Tyler A Sisley², Jonathan S Weissman^{13

14

15

16

17}, Britt Adamson^{18

19

20

21}, David R Liu^{22

23

24}

Affiliations

¹ Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
² Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA.
³ Howard Hughes Medical Institute, Harvard University, Cambridge, MA, USA.
⁴ Computational and Systems Biology Program, Massachusetts Institute of Technology, Cambridge, MA, USA.
⁵ Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA.
⁶ Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, USA.
⁷ Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, CA, USA.
⁸ Whitehead Institute for Biomedical Research, Cambridge, MA, USA.
⁹ Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.
¹⁰ Medical Scientist Training Program, University of California, San Francisco, San Francisco, CA, USA.
¹¹ Tetrad Graduate Program, University of California, San Francisco, San Francisco, CA, USA.
¹² Biomedical Sciences Graduate Program, University of California, San Francisco, San Francisco, CA, USA.
¹³ Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA. weissman@wi.mit.edu.
¹⁴ Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, CA, USA. weissman@wi.mit.edu.
¹⁵ Medical Scientist Training Program, University of California, San Francisco, San Francisco, CA, USA. weissman@wi.mit.edu.
¹⁶ Whitehead Institute for Biomedical Research, Cambridge, MA, USA. weissman@wi.mit.edu.
¹⁷ Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA. weissman@wi.mit.edu.
¹⁸ Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA. badamson@princeton.edu.
¹⁹ Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, CA, USA. badamson@princeton.edu.
²⁰ Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ, USA. badamson@princeton.edu.
²¹ Department of Molecular Biology, Princeton University, Princeton, NJ, USA. badamson@princeton.edu.
²² Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of Harvard and MIT, Cambridge, MA, USA. drliu@fas.harvard.edu.
²³ Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA. drliu@fas.harvard.edu.
²⁴ Howard Hughes Medical Institute, Harvard University, Cambridge, MA, USA. drliu@fas.harvard.edu.

^# Contributed equally.

PMID: 37853259
DOI: 10.1038/s41587-023-02028-8

Published Erratum

Author Correction: Efficient C•G-to-G•C base editors developed using CRISPRi screens, target-library analysis, and machine learning

Luke W Koblan et al. Nat Biotechnol. 2023 Nov.

. 2023 Nov;41(11):1655.

doi: 10.1038/s41587-023-02028-8.

Authors

Affiliations

¹ Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
² Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA.
³ Howard Hughes Medical Institute, Harvard University, Cambridge, MA, USA.
⁴ Computational and Systems Biology Program, Massachusetts Institute of Technology, Cambridge, MA, USA.
⁵ Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA.
⁶ Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, USA.
⁷ Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, CA, USA.
⁸ Whitehead Institute for Biomedical Research, Cambridge, MA, USA.
⁹ Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.
¹⁰ Medical Scientist Training Program, University of California, San Francisco, San Francisco, CA, USA.
¹¹ Tetrad Graduate Program, University of California, San Francisco, San Francisco, CA, USA.
¹² Biomedical Sciences Graduate Program, University of California, San Francisco, San Francisco, CA, USA.
¹³ Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA. weissman@wi.mit.edu.
¹⁴ Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, CA, USA. weissman@wi.mit.edu.
¹⁵ Medical Scientist Training Program, University of California, San Francisco, San Francisco, CA, USA. weissman@wi.mit.edu.
¹⁶ Whitehead Institute for Biomedical Research, Cambridge, MA, USA. weissman@wi.mit.edu.
¹⁷ Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA. weissman@wi.mit.edu.
¹⁸ Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA. badamson@princeton.edu.
¹⁹ Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, CA, USA. badamson@princeton.edu.
²⁰ Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ, USA. badamson@princeton.edu.
²¹ Department of Molecular Biology, Princeton University, Princeton, NJ, USA. badamson@princeton.edu.
²² Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of Harvard and MIT, Cambridge, MA, USA. drliu@fas.harvard.edu.
²³ Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA. drliu@fas.harvard.edu.
²⁴ Howard Hughes Medical Institute, Harvard University, Cambridge, MA, USA. drliu@fas.harvard.edu.

^# Contributed equally.

PMID: 37853259
DOI: 10.1038/s41587-023-02028-8

No abstract available

PubMed Disclaimer

Erratum for

Efficient C•G-to-G•C base editors developed using CRISPRi screens, target-library analysis, and machine learning.
Koblan LW, Arbab M, Shen MW, Hussmann JA, Anzalone AV, Doman JL, Newby GA, Yang D, Mok B, Replogle JM, Xu A, Sisley TA, Weissman JS, Adamson B, Liu DR. Koblan LW, et al. Nat Biotechnol. 2021 Nov;39(11):1414-1425. doi: 10.1038/s41587-021-00938-z. Epub 2021 Jun 28. Nat Biotechnol. 2021. PMID: 34183861 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: Efficient C•G-to-G•C base editors developed using CRISPRi screens, target-library analysis, and machine learning

Affiliations

Author Correction: Efficient C•G-to-G•C base editors developed using CRISPRi screens, target-library analysis, and machine learning

Authors

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources

Miscellaneous